Essex Investment Management’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-8,130	Closed	-$189K	–	491
2019 Q1	$189K	Sell	8,130 -690	-8%	-$16K	0.03%	349
2018 Q4	$182K	Buy	+8,820	New	+$182K	0.03%	346